| mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |